30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Esperion Therapeutics Inc (ESPR)

Track

Over the last 90 days, Esperion Therapeutics Inc. has seen three insider transactions, all of which were sales totaling $240,346.19. Notably, Sheldon L. Koenig, Officer and Director, sold shares worth $169,059.42 on June 17, 2026. This activity occurred against a backdrop of a 24.3% stock price increase over the past 90 days.
Stock chart
Ticker: ESPR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Looker Benjamin
Chief Legal Officer
2 sales — total 200,000 USD
Sale 17 Jun 2026
Value US$3,033,865.88 | Price 406.80 | Shares 68,789
Proposed sale 17 Jun 2026
Value US$3,608,662.13 | Price 273.71 | Shares 9,125
Sale 17 Jun 2026
Value US$2,708,431.76 | Price 301.09 | Shares 88,495
Proposed sale 17 Jun 2026
Value US$2,631,714.24 | Price 240.55 | Shares 80,349
Sale 17 Jun 2026
Value US$100,000.00 | Price 3.16 | Shares 1,000
Proposed sale 17 Jun 2026
Value US$100,000.00 | Price 3.15 | Shares 1,000
Sale 17 Mar 2026
Value US$15,428.72 | Price 2.70 | Shares 5,708
Proposed sale 17 Mar 2026
Value US$15,427.58 | Price 2.70 | Shares 5,708
Sale 17 Mar 2026
Value US$69,546.58 | Price 2.72 | Shares 25,578
Proposed sale 17 Mar 2026
Value US$69,551.70 | Price 2.72 | Shares 25,578
Sale 17 Mar 2026
Value US$17,376.92 | Price 2.71 | Shares 6,424
Proposed sale 17 Mar 2026
Value US$17,374.98 | Price 2.70 | Shares 6,424
Sale 20 Jan 2026
Value US$4,867.70 | Price 2.88 | Shares 1,689
Proposed sale 20 Jan 2026
Value US$4,867.02 | Price 2.88 | Shares 1,689
Sale 17 Dec 2025
Value US$177,200.21 | Price 3.67 | Shares 48,244
Proposed sale 17 Dec 2025
Value US$177,200.21 | Price 3.67 | Shares 48,244
Sale 17 Dec 2025
Value US$23,897.84 | Price 3.67 | Shares 6,517
Proposed sale 17 Dec 2025
Value US$23,897.19 | Price 3.67 | Shares 6,517
Sale 17 Dec 2025
Value US$26,904.78 | Price 3.67 | Shares 7,337
Proposed sale 17 Dec 2025
Value US$26,906.25 | Price 3.67 | Shares 7,337
Sale 17 Oct 2025
Value US$3,275.38 | Price 2.62 | Shares 1,248
Proposed sale 17 Oct 2025
Value US$3,275.38 | Price 2.62 | Shares 1,248
Planned sale 17 Sep 2025
Value US$19,785.17 | Price 2.81 | Shares 7,046
Proposed sale 17 Sep 2025
Value US$19,788.69 | Price 2.81 | Shares 7,046
Planned sale 17 Sep 2025
Value US$79,254.48 | Price 2.79 | Shares 28,427
Proposed sale 17 Sep 2025
Value US$79,240.27 | Price 2.79 | Shares 28,427
Sale 17 Sep 2025
Value US$17,572.67 | Price 2.80 | Shares 6,267
Proposed sale 17 Sep 2025
Value US$17,575.80 | Price 2.80 | Shares 6,267
Sale 17 Jul 2025
Value US$1,469.61 | Price 1.13 | Shares 1,304
Proposed sale 17 Jul 2025
Value US$1,469.35 | Price 1.13 | Shares 1,304
Sale 17 Jul 2025
Value US$12.26 | Price 1.12 | Shares 11
Proposed sale 17 Jul 2025
Value US$12.27 | Price 1.12 | Shares 11
Sale 17 Jun 2025
Value US$33,795.67 | Price 1.11 | Shares 30,474
Proposed sale 17 Jun 2025
Value US$33,792.63 | Price 1.11 | Shares 30,474
Sale 17 Jun 2025
Value US$7,398.14 | Price 1.15 | Shares 6,422
Proposed sale 17 Jun 2025
Value US$7,397.50 | Price 1.15 | Shares 6,422
Sale 17 Jun 2025
Value US$8,327.81 | Price 1.15 | Shares 7,229
Proposed sale 17 Jun 2025
Value US$8,329.25 | Price 1.15 | Shares 7,229
Sale 17 Apr 2025
Value US$105.62 | Price 0.98 | Shares 108
Proposed sale 17 Apr 2025
Value US$105.57 | Price 0.98 | Shares 108
Sale 17 Apr 2025
Value US$7.71 | Price 0.96 | Shares 8
Proposed sale 17 Apr 2025
Value US$7.71 | Price 0.96 | Shares 8
Sale 18 Mar 2025
Value US$19,622.69 | Price 1.50 | Shares 13,047
Proposed sale 18 Mar 2025
Value US$19,618.78 | Price 1.50 | Shares 13,047
Sale 18 Mar 2025
Value US$3,617.87 | Price 1.49 | Shares 2,433
Proposed sale 18 Mar 2025
Value US$3,618.12 | Price 1.49 | Shares 2,433
Sale 18 Mar 2025
Value US$5,242.40 | Price 1.48 | Shares 3,535
Proposed sale 18 Mar 2025
Value US$5,243.10 | Price 1.48 | Shares 3,535
Sale 19 Feb 2025
Value US$446.45 | Price 1.87 | Shares 239
Proposed sale 19 Feb 2025
Value US$446.43 | Price 1.87 | Shares 239
Sale 19 Feb 2025
Value US$20.46 | Price 1.86 | Shares 11
Proposed sale 19 Feb 2025
Value US$20.46 | Price 1.86 | Shares 11
Sale 17 Jan 2025
Value US$20.38 | Price 2.27 | Shares 9
Proposed sale 17 Jan 2025
Value US$20.29 | Price 2.25 | Shares 9
Sale 17 Jan 2025
Value US$277.98 | Price 2.26 | Shares 123
Proposed sale 17 Jan 2025
Value US$277.98 | Price 2.26 | Shares 123
Sale 17 Dec 2024
Value US$5,426.39 | Price 2.43 | Shares 2,234
Proposed sale 17 Dec 2024
Value US$5,425.71 | Price 2.43 | Shares 2,234
Sale 17 Dec 2024
Value US$7,865.88 | Price 2.42 | Shares 3,245
Proposed sale 17 Dec 2024
Value US$7,865.23 | Price 2.42 | Shares 3,245
Sale 17 Dec 2024
Value US$30,694.30 | Price 2.47 | Shares 12,447
Proposed sale 17 Dec 2024
Value US$30,698.04 | Price 2.47 | Shares 12,447
Sale 19 Nov 2024
Value US$426.50 | Price 2.17 | Shares 197
Proposed sale 19 Nov 2024
Value US$426.58 | Price 2.17 | Shares 197
Sale 17 Oct 2024
Value US$226.73 | Price 2.12 | Shares 107
Proposed sale 17 Oct 2024
Value US$226.75 | Price 2.12 | Shares 107
Sale 17 Sep 2024
Value US$26,131.80 | Price 1.80 | Shares 14,550
Proposed sale 17 Sep 2024
Value US$26,133.24 | Price 1.80 | Shares 14,550
Sale 17 Sep 2024
Value US$4,650.06 | Price 1.78 | Shares 2,608
Proposed sale 17 Sep 2024
Value US$4,650.85 | Price 1.78 | Shares 2,608
Proposed sale 17 Sep 2024
Value US$6,015.47 | Price 1.78 | Shares 3,381
Sale 19 Aug 2024
Value US$410.61 | Price 1.95 | Shares 211
Proposed sale 19 Aug 2024
Value US$410.50 | Price 1.95 | Shares 211
Sale 17 Jul 2024
Value US$2,383.28 | Price 2.60 | Shares 917
Sale 17 Jul 2024
Value US$279.40 | Price 2.59 | Shares 108
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17 S Sale
3.9
Looker Benjamin

Chief Legal Officer

Officer
68,789 +18.2%
406.80
US$3,033,866 		68,789 +18.2% 406.80 US$3,033,866
2026-06-18 2026-06-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
88,495 +0.8%
301.09
US$2,708,432 		88,495 +0.8% 301.09 US$2,708,432
2026-06-18 2026-06-17 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
7,435 -25.5%
55.59
US$1,791,018 		7,435 -25.5% 55.59 US$1,791,018
2026-06-17 2026-06-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
1,000
3.15
US$100,000 		1,000 3.15 US$100,000
2026-06-17 2026-06-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
1,000
3.15
US$100,000 		1,000 3.15 US$100,000
2026-06-17 2026-06-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
1,000
3.15
US$100,000 		1,000 3.15 US$100,000
2026-03-18 2026-03-17 S Sale
3.9
Looker Benjamin

Chief Legal Officer

Officer
5,708 -0.8%
2.70
US$15,429 		5,708 -0.8% 2.70 US$15,429
2026-03-18 2026-03-17 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
25,578 -1.2%
2.72
US$69,547 		25,578 -1.2% 2.72 US$69,547
2026-03-18 2026-03-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
6,424 -0.9%
2.71
US$17,377 		6,424 -0.9% 2.71 US$17,377
2026-03-17 2026-03-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
6,424
2.70
US$17,375 		6,424 2.70 US$17,375
2026-03-17 2026-03-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
5,708
2.70
US$15,428 		5,708 2.70 US$15,428
2026-03-17 2026-03-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
25,578
2.72
US$69,552 		25,578 2.72 US$69,552
2026-01-21 2026-01-20 S Sale
3.9
Looker Benjamin

General Counsel

Officer
1,689 -0.4%
2.88
US$4,868 		1,689 -0.4% 2.88 US$4,868
2026-01-20 2026-01-20 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
1,689
2.88
US$4,867 		1,689 2.88 US$4,867
2025-12-18 2025-12-17 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
48,244 -3.2%
3.67
US$177,200 		48,244 -3.2% 3.67 US$177,200
2025-12-18 2025-12-17 S Sale
3.9
Looker Benjamin

General Counsel

Officer
6,517 -1.7%
3.67
US$23,898 		6,517 -1.7% 3.67 US$23,898
2025-12-18 2025-12-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
7,337 -1.5%
3.67
US$26,905 		7,337 -1.5% 3.67 US$26,905
2025-12-17 2025-12-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
48,244
3.67
US$177,200 		48,244 3.67 US$177,200
2025-12-17 2025-12-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
6,517
3.67
US$23,897 		6,517 3.67 US$23,897
2025-12-17 2025-12-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
7,337
3.67
US$26,906 		7,337 3.67 US$26,906
2025-10-20 2025-10-17 S Sale
3.9
Looker Benjamin

General Counsel

Officer
1,248 -0.3%
2.62
US$3,275 		1,248 -0.3% 2.62 US$3,275
2025-10-17 2025-10-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
1,248
2.62
US$3,275 		1,248 2.62 US$3,275
2025-09-18 2025-09-17 PlS Planned sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
7,046 -1.5%
2.81
US$19,785 		7,046 -1.5% 2.81 US$19,785
2025-09-18 2025-09-17 PlS Planned sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
28,427 -1.8%
2.79
US$79,254 		28,427 -1.8% 2.79 US$79,254
2025-09-18 2025-09-17 S Sale
3.9
Looker Benjamin

General Counsel

Officer
6,267 -1.6%
2.80
US$17,573 		6,267 -1.6% 2.80 US$17,573
2025-09-17 2025-09-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
28,427
2.79
US$79,240 		28,427 2.79 US$79,240
2025-09-17 2025-09-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
7,046
2.81
US$19,789 		7,046 2.81 US$19,789
2025-09-17 2025-09-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
6,267
2.80
US$17,576 		6,267 2.80 US$17,576
2025-07-18 2025-07-17 S Sale
3.9
Looker Benjamin

General Counsel

Officer
1,304 -0.3%
1.13
US$1,470 		1,304 -0.3% 1.13 US$1,470
2025-07-18 2025-07-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
11 -0.0%
1.12
US$12 		11 -0.0% 1.12 US$12
2025-07-17 2025-07-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
1,304
1.13
US$1,469 		1,304 1.13 US$1,469
2025-07-17 2025-07-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
11
1.12
US$12 		11 1.12 US$12
2025-06-18 2025-06-17 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
30,474 -1.9%
1.11
US$33,796 		30,474 -1.9% 1.11 US$33,796
2025-06-18 2025-06-17 S Sale
3.9
Looker Benjamin

General Counsel

Officer
6,422 -1.6%
1.15
US$7,398 		6,422 -1.6% 1.15 US$7,398
2025-06-18 2025-06-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
7,229 -1.5%
1.15
US$8,328 		7,229 -1.5% 1.15 US$8,328
2025-06-17 2025-06-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
30,474
1.11
US$33,793 		30,474 1.11 US$33,793
2025-06-17 2025-06-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
7,229
1.15
US$8,329 		7,229 1.15 US$8,329
2025-06-17 2025-06-17 PrS Proposed sale
3.9
Looker Benjamin

Officer

Officer
6,422
1.15
US$7,398 		6,422 1.15 US$7,398
2025-04-21 2025-04-17 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
108 -0.0%
0.98
US$106 		108 -0.0% 0.98 US$106
2025-04-21 2025-04-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
8 -0.0%
0.96
US$8 		8 -0.0% 0.96 US$8
2025-04-17 2025-04-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
8
0.96
US$8 		8 0.96 US$8
2025-04-17 2025-04-17 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
108
0.98
US$106 		108 0.98 US$106
2025-03-19 2025-03-18 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
13,047 -0.8%
1.50
US$19,623 		13,047 -0.8% 1.50 US$19,623
2025-03-19 2025-03-18 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
2,433 -0.7%
1.49
US$3,618 		2,433 -0.7% 1.49 US$3,618
2025-03-19 2025-03-18 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
3,535 -0.7%
1.48
US$5,242 		3,535 -0.7% 1.48 US$5,242
2025-03-18 2025-03-18 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
2,433
1.49
US$3,618 		2,433 1.49 US$3,618
2025-03-18 2025-03-18 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
3,535
1.48
US$5,243 		3,535 1.48 US$5,243
2025-03-18 2025-03-18 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
13,047
1.50
US$19,619 		13,047 1.50 US$19,619
2025-02-20 2025-02-19 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
239 -0.1%
1.87
US$446 		239 -0.1% 1.87 US$446
2025-02-20 2025-02-19 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
11 -0.0%
1.86
US$20 		11 -0.0% 1.86 US$20
2025-02-19 2025-02-19 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
239
1.87
US$446 		239 1.87 US$446
2025-02-19 2025-02-19 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
11
1.86
US$20 		11 1.86 US$20
2025-01-21 2025-01-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
9 -0.0%
2.27
US$20 		9 -0.0% 2.27 US$20
2025-01-21 2025-01-17 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
123 -0.1%
2.26
US$278 		123 -0.1% 2.26 US$278
2025-01-17 2025-01-17 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
123
2.26
US$278 		123 2.26 US$278
2025-01-17 2025-01-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
9
2.25
US$20 		9 2.25 US$20
2024-12-18 2024-12-17 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
2,234 -1.4%
2.43
US$5,426 		2,234 -1.4% 2.43 US$5,426
2024-12-18 2024-12-17 S Sale
3.7
Halladay Benjamin

Chief Financial Officer

Officer
3,245 -1.3%
2.42
US$7,866 		3,245 -1.3% 2.42 US$7,866
2024-12-18 2024-12-17 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
12,447 -1.7%
2.47
US$30,694 		12,447 -1.7% 2.47 US$30,694
2024-12-17 2024-12-17 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
2,234
2.43
US$5,426 		2,234 2.43 US$5,426
2024-12-17 2024-12-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
12,447
2.47
US$30,698 		12,447 2.47 US$30,698
2024-12-17 2024-12-17 PrS Proposed sale
3.7
Halladay Benjamin

Officer

Officer
3,245
2.42
US$7,865 		3,245 2.42 US$7,865
2024-11-20 2024-11-19 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
197 -0.1%
2.17
US$427 		197 -0.1% 2.17 US$427
2024-11-19 2024-11-19 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
197
2.17
US$427 		197 2.17 US$427
2024-10-18 2024-10-17 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
107 -0.1%
2.12
US$227 		107 -0.1% 2.12 US$227
2024-10-17 2024-10-17 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
107
2.12
US$227 		107 2.12 US$227
2024-09-18 2024-09-17 S Sale
3.0
Koenig Sheldon L.

President and CEO

Executive Director
14,550 -1.9%
1.80
US$26,132 		14,550 -1.9% 1.80 US$26,132
2024-09-18 2024-09-17 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
2,608 -1.6%
1.78
US$4,650 		2,608 -1.6% 1.78 US$4,650
2024-09-17 2024-09-17 PrS Proposed sale
3.9
Foody Joanne M.

Officer

Officer
3,381
1.78
US$6,015 		3,381 1.78 US$6,015
2024-09-17 2024-09-17 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
2,608
1.78
US$4,651 		2,608 1.78 US$4,651
2024-09-17 2024-09-17 PrS Proposed sale
3.0
Koenig Sheldon L.

Officer; Director

Executive Director
14,550
1.80
US$26,133 		14,550 1.80 US$26,133
2024-08-20 2024-08-19 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
211 -0.1%
1.95
US$411 		211 -0.1% 1.95 US$411
2024-08-19 2024-08-19 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
211
1.95
US$410 		211 1.95 US$410
2024-07-19 2024-07-17 S Sale
3.9
Foody Joanne M.

Chief Medical Officer

Officer
917 -0.3%
2.60
US$2,383 		917 -0.3% 2.60 US$2,383
2024-07-19 2024-07-17 S Sale
3.1
Warren Eric

Chief Commercial Officer

Officer
108 -0.1%
2.59
US$279 		108 -0.1% 2.59 US$279
Explore more

More insider trading research around Esperion Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America